Dabei Tang

729 total citations
26 papers, 575 citations indexed

About

Dabei Tang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dabei Tang has authored 26 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Dabei Tang's work include MicroRNA in disease regulation (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer-related molecular mechanisms research (3 papers). Dabei Tang is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer-related molecular mechanisms research (3 papers). Dabei Tang collaborates with scholars based in China and United States. Dabei Tang's co-authors include Shanqi Xu, Qingyuan Zhang, Wenhui Zhao, Shu Zhao, Qingyuan Zhang, Jingxuan Wang, Ying Song, Wenjie Ma, Hong Zhao and Jincai Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Dabei Tang

25 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dabei Tang China 13 308 293 206 104 71 26 575
A.M. Merino Spain 11 255 0.8× 270 0.9× 272 1.3× 48 0.5× 86 1.2× 14 589
María C. Díaz Flaqué Argentina 14 299 1.0× 108 0.4× 314 1.5× 96 0.9× 52 0.7× 23 627
Yan Qiu China 17 315 1.0× 282 1.0× 227 1.1× 25 0.2× 97 1.4× 39 639
Chaoju Gong China 14 364 1.2× 216 0.7× 211 1.0× 31 0.3× 80 1.1× 28 619
Zejun Fang China 15 381 1.2× 196 0.7× 169 0.8× 24 0.2× 77 1.1× 27 548
Lubna Qamar United States 13 397 1.3× 195 0.7× 117 0.6× 27 0.3× 58 0.8× 20 557
Grace L. Wong United States 9 341 1.1× 150 0.5× 229 1.1× 31 0.3× 77 1.1× 13 578
Eyal Kalo Israel 9 464 1.5× 157 0.5× 334 1.6× 46 0.4× 40 0.6× 10 663
Sara G. Manore United States 9 313 1.0× 126 0.4× 256 1.2× 30 0.3× 82 1.2× 13 579

Countries citing papers authored by Dabei Tang

Since Specialization
Citations

This map shows the geographic impact of Dabei Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dabei Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dabei Tang more than expected).

Fields of papers citing papers by Dabei Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dabei Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dabei Tang. The network helps show where Dabei Tang may publish in the future.

Co-authorship network of co-authors of Dabei Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Dabei Tang. A scholar is included among the top collaborators of Dabei Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dabei Tang. Dabei Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Jianli, Shengnan Sun, Xiaowen Tang, et al.. (2025). Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer. British Journal of Cancer. 134(4). 685–696.
3.
Zhao, Wenhui, Jianli Ma, Qingyuan Zhang, et al.. (2024). Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. Cell Biology International. 48(4). 496–509. 6 indexed citations
4.
5.
Zhao, Yanfang, Wenjia Su, Xiaoyu Shan, et al.. (2021). High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: a retrospective study. BMC Pharmacology and Toxicology. 22(1). 63–63. 6 indexed citations
6.
Tang, Dabei, Wenjia Su, Xiaowei Wang, et al.. (2020). Clinicopathologic significance of MYD88 L265P mutation and expression of TLR4 and P-STAT3 in primary central nervous system diffuse large B-cell lymphomas. Brain Tumor Pathology. 38(1). 50–58. 4 indexed citations
7.
Su, Wenjia, Xingjian Niu, Hongfei Ji, et al.. (2020). A novel classification based on B-cell receptor signal gene expression correlates with prognosis in primary breast diffuse large B-cell lymphoma. Journal of Cancer. 11(9). 2431–2441. 4 indexed citations
8.
9.
10.
Ma, Jianli, Zhong Chu, Jessica Bo Li Lu, et al.. (2017). The Cytochrome P450 Enzyme Responsible for the Production of (Z)‐Norendoxifen in vitro. Chemistry & Biodiversity. 15(1). 3 indexed citations
11.
Wang, Jingxuan, Ying Song, Shu Zhao, et al.. (2015). miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1. Oncology Reports. 34(2). 995–1002. 60 indexed citations
12.
Wang, Jingxuan, Ying Song, Shu Zhao, et al.. (2015). RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. PLoS ONE. 10(7). e0133964–e0133964. 24 indexed citations
13.
Zhao, Wenhui, Shuo Li, Dabei Tang, et al.. (2014). Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment. European Journal of Endocrinology. 171(4). 527–533. 20 indexed citations
14.
Tang, Dabei, Ying Piao, Shu Zhao, et al.. (2014). Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Medical Oncology. 31(7). 26–26. 27 indexed citations
15.
Wang, Jincai, Hong Zhao, Dabei Tang, et al.. (2013). Overexpressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis. Cancer Biotherapy and Radiopharmaceuticals. 28(4). 283–288. 39 indexed citations
16.
Tang, Dabei, Qingyuan Zhang, Shu Zhao, et al.. (2013). The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer. Clinical Biochemistry. 46(10-11). 926–932. 48 indexed citations
17.
Zhao, Shu, Wenjie Ma, Minghui Zhang, et al.. (2012). High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Medical Oncology. 30(1). 335–335. 76 indexed citations
18.
Wang, Jingxuan, Ying Song, Shanqi Xu, et al.. (2011). Down-regulation of ICBP90 contributes to doxorubicin resistance. European Journal of Pharmacology. 656(1-3). 33–38. 8 indexed citations
19.
Tang, Dabei, Shanqi Xu, Qingyuan Zhang, & Wenhui Zhao. (2011). The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer. Medical Oncology. 29(2). 526–533. 119 indexed citations
20.
Zhang, Qingyuan, Dabei Tang, & Hong Zhao. (2010). Immunological Therapies Can Relieve Aromatase Inhibitor-Related Joint Symptoms in Breast Cancer Survivors. American Journal of Clinical Oncology. 33(6). 557–560. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.M. Merino Breakdown of academic impact, for papers by María C. Díaz Flaqué Breakdown of academic impact, for papers by Yan Qiu Breakdown of academic impact, for papers by Chaoju Gong Breakdown of academic impact, for papers by Zejun Fang Breakdown of academic impact, for papers by Lubna Qamar Breakdown of academic impact, for papers by Grace L. Wong Breakdown of academic impact, for papers by Eyal Kalo Breakdown of academic impact, for papers by Sara G. Manore
Rankless by CCL
2026